Chen X, Ji X, Lao Z, Pan B, Qian Y, Yang W
J Orthop Translat. 2025; 51:13-23.
PMID: 39902099
PMC: 11787699.
DOI: 10.1016/j.jot.2024.12.003.
Reichelt P, Bernhart S, Platzbecker U, Cross M
Genes (Basel). 2025; 15(12.
PMID: 39766892
PMC: 11675194.
DOI: 10.3390/genes15121625.
Wang S, Shao D, Gao X, Zhao P, Kong F, Deng J
Front Immunol. 2024; 15:1480701.
PMID: 39430767
PMC: 11486717.
DOI: 10.3389/fimmu.2024.1480701.
Li X, Cho Y, Cho Y, Cho Y, Han Y, Zhou M
bioRxiv. 2024; .
PMID: 38979373
PMC: 11230290.
DOI: 10.1101/2024.06.21.600079.
Zhao Y, Su C, He B, Nie R, Wang Y, Ma J
Nat Commun. 2023; 14(1):8190.
PMID: 38081828
PMC: 10713551.
DOI: 10.1038/s41467-023-44023-2.
Blimp-1/PRDM1 and Hr3/RORβ specify the blue-sensitive photoreceptor subtype in by repressing the hippo pathway.
Bunker J, Bashir M, Bailey S, Boodram P, Perry A, Delaney R
Front Cell Dev Biol. 2023; 11:1058961.
PMID: 36960411
PMC: 10027706.
DOI: 10.3389/fcell.2023.1058961.
Mechanism of Guilu Erxian ointment based on targeted metabolomics in intervening fertilization and embryo transfer outcome in older patients with poor ovarian response of kidney-qi deficiency type.
Ma Y, Song J, Cao X, Sun Z
Front Endocrinol (Lausanne). 2023; 14:1045384.
PMID: 36742408
PMC: 9897313.
DOI: 10.3389/fendo.2023.1045384.
YAP antagonizes TEAD-mediated AR signaling and prostate cancer growth.
Li X, Zhuo S, Cho Y, Liu Y, Yang Y, Zhu J
EMBO J. 2023; 42(4):e112184.
PMID: 36588499
PMC: 9929633.
DOI: 10.15252/embj.2022112184.
The Hippo pathway effector YAP inhibits HIF2 signaling and ccRCC tumor growth.
Li X, Cho Y, Zhu J, Zhuo S, Jiang J
Cell Discov. 2022; 8(1):103.
PMID: 36202785
PMC: 9537283.
DOI: 10.1038/s41421-022-00465-4.
YAP inhibits ERα and ER breast cancer growth by disrupting a TEAD-ERα signaling axis.
Li X, Zhuo S, Zhuang T, Cho Y, Wu G, Liu Y
Nat Commun. 2022; 13(1):3075.
PMID: 35654829
PMC: 9163075.
DOI: 10.1038/s41467-022-30831-5.
Low-Dose Radiation Can Cause Epigenetic Alterations Associated With Impairments in Both Male and Female Reproductive Cells.
Leung C, Yang Y, Yu K, Tam N, Chan T, Lin X
Front Genet. 2021; 12:710143.
PMID: 34408775
PMC: 8365519.
DOI: 10.3389/fgene.2021.710143.
A newly identified Hippo homologue from the oriental river prawn Macrobrachium nipponense is involved in the antimicrobial immune response.
Huang Y, Ren Q
Vet Res. 2021; 52(1):76.
PMID: 34078461
PMC: 8170997.
DOI: 10.1186/s13567-021-00945-7.
Hippo-Independent Regulation of Yki/Yap/Taz: A Non-canonical View.
Cho Y, Jiang J
Front Cell Dev Biol. 2021; 9:658481.
PMID: 33869224
PMC: 8047194.
DOI: 10.3389/fcell.2021.658481.
RGS12 is a novel tumor suppressor in osteosarcoma that inhibits YAP-TEAD1-Ezrin signaling.
Li Y, Liu M, Yang S, Fuller A, Eisinger-Mathason T, Yang S
Oncogene. 2021; 40(14):2553-2566.
PMID: 33686240
PMC: 8694668.
DOI: 10.1038/s41388-020-01599-z.
Rox8 promotes microRNA-dependent messenger RNA decay.
Guo X, Sun Y, Azad T, Janse van Rensburg H, Luo J, Yang S
Proc Natl Acad Sci U S A. 2020; 117(48):30520-30530.
PMID: 33203680
PMC: 7720199.
DOI: 10.1073/pnas.2013449117.
Phase separation of TAZ compartmentalizes the transcription machinery to promote gene expression.
Lu Y, Wu T, Gutman O, Lu H, Zhou Q, Henis Y
Nat Cell Biol. 2020; 22(4):453-464.
PMID: 32203417
PMC: 11044910.
DOI: 10.1038/s41556-020-0485-0.
CDK7 regulates organ size and tumor growth by safeguarding the Hippo pathway effector Yki/Yap/Taz in the nucleus.
Cho Y, Li S, Wang X, Zhu J, Zhuo S, Han Y
Genes Dev. 2019; 34(1-2):53-71.
PMID: 31857346
PMC: 6938674.
DOI: 10.1101/gad.333146.119.
Identification of Hub Genes and Key Pathways Associated With Bipolar Disorder Based on Weighted Gene Co-expression Network Analysis.
Liu Y, Gu H, Zhu J, Niu Y, Zhang C, Guo G
Front Physiol. 2019; 10:1081.
PMID: 31481902
PMC: 6710482.
DOI: 10.3389/fphys.2019.01081.
Etv2 transcriptionally regulates Yes1 and promotes cell proliferation during embryogenesis.
Singh B, Gong W, Das S, Theisen J, Sierra-Pagan J, Yannopoulos D
Sci Rep. 2019; 9(1):9736.
PMID: 31278282
PMC: 6611806.
DOI: 10.1038/s41598-019-45841-5.
Regulation of Yki/Yap subcellular localization and Hpo signaling by a nuclear kinase PRP4K.
Cho Y, Zhu J, Li S, Wang B, Han Y, Jiang J
Nat Commun. 2018; 9(1):1657.
PMID: 29695716
PMC: 5916879.
DOI: 10.1038/s41467-018-04090-2.